Neuromodulation Market .pdf
Original filename: Neuromodulation Market.pdf
This PDF 1.4 document has been generated by Online2PDF.com, and has been sent on pdf-archive.com on 20/04/2018 at 10:14, from IP address 1.23.x.x.
The current document download page has been viewed 633 times.
File size: 168 KB (7 pages).
Privacy: public file
Download original PDF file
Global Industry Analysis, Trends, Market Size and Forecasts up to 2023
A latest report has been added to the wide database of Neuromodulation Market by Infinium Global Research. This report studies the
Neuromodulation Market by technology (deep brain, spinal cord, gastric, sacral, vagus nerve stimulation), application (chronic pain, parkinson’s
disease, dystonia, essential tremor, gastroparesis, OCD, refractory epilepsy, TRD, urinary fecal incontinence) market status and outlook of global
and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments &
countries in recent years and to forecast the values for the next six years. Neuromodulation Market provides opportunities in micro markets for
stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in
the Neuromodulation Market. According to report the global neuromodulation market is projected to grow at a CAGR of 10.9% over the forecast
period of 2017-2023.
Neuromodulation includes treatments that involve stimulation or administration of medications directly to the body’s nervous system for
therapeutic purposes. The target cells for stimulation include nerves in the central and peripheral nervous systems, the autonomic nervous
system, and the deep cell nuclei of the brain, resulting in modulation of their activity. Neuromodulation includes several modalities, and is a
cross-disciplinary approach to pain control and neurologic dysfunction. Neuromodulation can be used to treat movement disorders, spasticity,
and epilepsy, as well as pain syndromes. Devices are implanted which can either include drug delivery pumps or neural stimulators. The most
common type is spinal cord stimulation, which is used for back or lower extremity pain. Spinal cord stimulation involves electrical stimulation of
the spinal cord to interrupt pain signals from the spinal cord to the brain, and to trade a painful sensation with a more pleasant tingling sensation.
The technology has been present since the 1960s and in the past decade has become highly effective in the treatment of pain. In addition to
chronic pain relief, other neuromodulation treatments now used include deep brain stimulation for essential tremor, Parkinson’s disease,
dystonia, epilepsy and disorders such as depression, obsessive compulsive disorder and Tourette syndrome; sacral nerve stimulation for pelvic
disorders and incontinence; gastric and colonic stimulation for gastrointestinal disorders such as dysmotility or obesity; vagus nerve stimulation
for epilepsy, obesity or depression; carotid artery stimulation for hypertension; and spinal cord stimulation for ischemic disease such as angina
and peripheral vascular disease.
Rise in base of geriatric population, increasing number of patients with neurological disorders, strong product pipeline with various innovations,
increasing number of target applications, and increasing demand from emerging countries are the primary driving factors contributing for the
growth of this market. Neuromodulation is reversible and adjustable, in which physicians can on-invasively manage the electrical parameters
with a programmer to effectively control disease symptoms. However, there are certain factors which could hamper the growth of this market,
includes unfavorable reimbursement scenario and lack of sufficient number of trained professionals to treat disorders.
The report on global neuromodulation market covers segments such as, technology and application. On the basis of technology the global
neuromodulation market is categorized into deep brain stimulation, spinal cord stimulation, gastric stimulation, sacral nerve stimulation, vagus
nerve stimulation and others. On the basis of application the global neuromodulation market is categorized into chronic pain, parkinson’s
disease, dystonia, essential tremor, gastroparesis, obsessive compulsive disorder (OCD), refractory epilepsy, treatment resistant depression
(TRD), urinary fecal incontinence and other applications.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the
key trends and market size for each geography is provided over the period of 2015-2023.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South
Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S.
drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the
market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x%
over the period of 2017-2023.
The report provides profiles of the companies in the global neuromodulation market such as, Medtronic plc, Boston Scientific Corporation, St.
Jude Medical, Cyberonics, Cochlear Ltd., Advanced Bionics, Sonova Group, Nevro Corporation, Neuronetics, Inc. and Greatbatch.
Make an Enquiry
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights
on the factors that are driving and restraining the global neuromodulation market. Moreover, IGR-Growth Matrix analysis given in the report
brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using
analytical tools such as Porter's five forces analysis and DRO analysis of neuromodulation market. Moreover, the study highlights current market
trends and provides forecast from 2017-2023. We also have highlighted future trends in the neuromodulation market that will impact the
demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of
the leading players. This report will help manufacturers, suppliers and distributors of the neuromodulation market to understand the present and
future trends in this market and formulate their strategies accordingly.
Get a Sample Request
Table of Contents:1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Neuromodulation Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Neuromodulation Market
4. Global Neuromodulation Market by Technology
4.1. Deep Brain Stimulation
4.2. Spinal Cord Stimulation
4.3. Gastric Stimulation
4.4. Sacral Nerve Stimulation
4.5. Vagus Nerve Stimulation
5. Global Neuromodulation Market by Application
5.1. Chronic Pain
5.2. Parkinson’s Disease
5.4. Essential Tremor
5.6. Obsessive Compulsive Disorder(OCD)
5.7. Refractory Epilepsy
5.8. Treatment Resistant Depression (TRD)
5.9. Urinary Fecal Incontinence
5.10. Other Applications
6. Global Neuromodulation Market by Region 2017-2023
6.1. North America
6.1.1. North America Neuromodulation Market by Technology
6.1.2. North America Neuromodulation Market by Application
6.1.3. North America Neuromodulation Market by Country
6.2.1. Europe Neuromodulation Market by Technology
6.2.2. Europe Neuromodulation Market by Application
6.2.3. Europe Neuromodulation Market by Country
6.3.1. Asia-Pacific Neuromodulation Market by Technology
6.3.2. Asia-Pacific Neuromodulation Market by Application
6.3.3. Asia-Pacific Neuromodulation Market by Country
6.4.1. RoW Neuromodulation Market by Technology
6.4.2. RoW Neuromodulation Market by Application
6.4.3. RoW Neuromodulation Market by Sub-region
7. Company Covered
7.1. Medtronic Plc
7.2. Boston Scientific Corporation
7.3. St. Jude Medical
7.5. Cochlear Ltd.
7.6. Advanced Bionics
7.7. Sonova Group
7.8. Nevro Corporation
7.9. Neuronetics, Inc.
Click the Below Full Report Link: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_neuromodulation_market